Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Infusion reactions related to infliximab therapy are not usually associated with drug discontinuation.

Infusion reactions related to infliximab therapy are not usually associated with drug discontinuation. J Rheumatol. 2012 Aug; 39(8):1500-2.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.